Actinium Pharmaceuticals (ATNM) Short Interest Ratio & Short Volume → Urgent dollar warning (From Stansberry Research) (Ad) Free ATNM Stock Alerts $8.75 +0.97 (+12.47%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Actinium Pharmaceuticals Short Interest DataCurrent Short Volume1,980,000 sharesPrevious Short Volume2,190,000 sharesChange Vs. Previous Month-9.59%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover5.6Last Record DateApril 15, 2024Outstanding Shares29,780,000 sharesPercentage of Shares Shorted6.65%Today's Trading Volume681,831 sharesAverage Trading Volume324,886 sharesToday's Volume Vs. Average210% Short Selling Actinium Pharmaceuticals ? Sign up to receive the latest short interest report for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATNM Short Interest Over TimeATNM Days to Cover Over TimeATNM Percentage of Float Shorted Over Time Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Actinium Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,980,000 shares $0.00 -9.6%N/A5.6 $0.00 3/31/20242,190,000 shares $0.00 +20.3%N/A6.6 $0.00 3/15/20241,820,000 shares $12.29 million +1.1%N/A5.8 $6.75 2/29/20241,800,000 shares $15.35 million -3.2%N/A8.3 $8.53 2/15/20241,860,000 shares $0.00 +0.5%N/A8.5 $0.00 1/31/20241,850,000 shares $9.95 million -7.0%N/A9.1 $5.38 Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,990,000 shares $0.00 +2.1%N/A9.4 $0.00 12/31/20231,950,000 shares $0.00 +2.6%N/A9.4 $0.00 12/15/20231,900,000 shares $0.00 -6.9%N/A9.4 $0.00 11/30/20232,040,000 shares $9.34 million +10.3%N/A10.5 $4.58 11/15/20231,850,000 shares $0.00 -7.5%N/A9.7 $0.00 10/31/20232,000,000 shares $0.00 -2.0%N/A10.7 $0.00 10/15/20232,040,000 shares $0.00 -1.0%N/A12.1 $0.00 9/30/20232,060,000 shares $0.00 +5.6%N/A12.2 $0.00 9/15/20231,950,000 shares $0.00 -5.3%N/A11.7 $0.00 8/31/20232,060,000 shares $0.00 -2.4%N/A9.2 $0.00 8/15/20232,110,000 shares $0.00 No ChangeN/A9.9 $0.00 7/31/20232,110,000 shares $0.00 -0.9%N/A9.7 $0.00 7/15/20232,130,000 shares $0.00 -0.5%N/A8.8 $0.00 6/30/20232,140,000 shares $0.00 +27.4%N/A8.7 $0.00 6/15/20231,680,000 shares $0.00 +37.7%N/A6.6 $0.00 5/31/20231,220,000 shares $10.13 million -29.1%N/A5.8 $8.30 5/15/20231,720,000 shares $0.00 +30.3%N/A4.8 $0.00 4/30/20231,320,000 shares $0.00 -27.5%N/A3.4 $0.00 4/15/20231,820,000 shares $0.00 -4.2%N/A4.7 $0.00 3/31/20231,900,000 shares $17.96 million +31.9%N/A4.6 $9.45 3/15/20231,440,000 shares $13.45 million -2.0%N/A3.5 $9.34 2/28/20231,470,000 shares $14.19 million -9.8%N/A3.6 $9.65 2/15/20231,630,000 shares $0.00 +4.5%N/A3.9 $0.00 1/31/20231,560,000 shares $18.28 million +39.3%N/A5 $11.72 1/15/20231,120,000 shares $0.00 +0.9%N/A2 $0.00 12/30/20221,110,000 shares $11.82 million -3.5%N/A2.1 $10.65 12/15/20221,150,000 shares $0.00 -6.5%N/A2.2 $0.00 11/30/20221,230,000 shares $0.00 +36.8%N/A2.5 $0.00 11/15/2022899,200 shares $0.00 +84.9%N/A1.8 $0.00 10/31/2022486,400 shares $0.00 +23.2%N/A1.1 $0.00 10/15/2022394,900 shares $0.00 +5.3%N/A2.8 $0.00 9/30/2022374,900 shares $0.00 +6.4%N/A2.8 $0.00 9/15/2022352,500 shares $0.00 -10.2%N/A2.5 $0.00 8/31/2022392,700 shares $0.00 +5.7%N/A2.9 $0.00Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… ATNM Short Interest - Frequently Asked Questions What is Actinium Pharmaceuticals' current short interest? Short interest is the volume of Actinium Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,980,000 shares of ATNM short. Learn More on Actinium Pharmaceuticals' current short interest. What is a good short interest ratio for Actinium Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATNM shares currently have a short interest ratio of 6.0. Learn More on Actinium Pharmaceuticals's short interest ratio. Which institutional investors are shorting Actinium Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Actinium Pharmaceuticals: Concourse Financial Group Securities Inc., Simplex Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Actinium Pharmaceuticals' short interest increasing or decreasing? Actinium Pharmaceuticals saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,980,000 shares, a drop of 9.6% from the previous total of 2,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Actinium Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Actinium Pharmaceuticals: Renovaro Inc. (2.16%), Conduit Pharmaceuticals Inc. (0.40%), Foghorn Therapeutics Inc. (6.31%), Organigram Holdings Inc. (5.44%), XBiotech Inc. (3.40%), Aldeyra Therapeutics, Inc (4.17%), 2seventy bio, Inc. (13.60%), Galectin Therapeutics Inc. (6.47%), Ovid Therapeutics Inc. (4.78%), Immutep Limited (1.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Actinium Pharmaceuticals stock? Short selling ATNM is an investing strategy that aims to generate trading profit from Actinium Pharmaceuticals as its price is falling. ATNM shares are trading up $0.87 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Actinium Pharmaceuticals? A short squeeze for Actinium Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNM, which in turn drives the price of the stock up even further. How often is Actinium Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Renovaro Short Squeeze Conduit Pharmaceuticals Short Squeeze Foghorn Therapeutics Short Squeeze Organigram Short Squeeze XBiotech Short Squeeze Aldeyra Therapeutics Short Squeeze 2seventy bio Short Squeeze Galectin Therapeutics Short Squeeze Ovid Therapeutics Short Squeeze Immutep Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:ATNM) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressYour bank is lying to you.MyBankTrackerTrump just won 2024Porter & CompanyA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders